PT  - JOURNAL ARTICLE
AU  - Schiff, Steven J.
AU  - Kulkarni, Abhaya V.
AU  - Kabachelor, Edith Mbabazi
AU  - Mugamba, John
AU  - Ssenyonga, Peter
AU  - Donnelly, Ruth
AU  - Levenbach, Jody
AU  - Monga, Vishal
AU  - Peterson, Mallory
AU  - Cherukuri, Venkateswararao
AU  - Warf, Benjamin C.
TI  - Brain growth and neurodevelopment after surgical treatment of infant post-infectious hydrocephalus in sub-Saharan Africa
AID  - 10.1101/2020.11.10.20229328
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.10.20229328
4099  - http://medrxiv.org/content/early/2020/11/13/2020.11.10.20229328.short
4100  - http://medrxiv.org/content/early/2020/11/13/2020.11.10.20229328.full
AB  - Importance Post-infectious hydrocephalus in infants is a major public health burden in sub-Saharan Africa.Objective To determine long-term brain growth and cognitive outcome after surgical treatment of infant post-infectious hydrocephalus in Uganda.Design Prospective follow-up of a previously randomized cohort.Setting Single center in Mbale, Uganda.Participants Infants (<180 days old) with post-infectious hydrocephalus.Interventions Endoscopic or shunt surgery.Main outcomes Bayley Scales of Infant Development (BSID-3) and brain volume on computed tomography (raw and normalized for age and sex) at 2 years after treatment.Results Eighty-nine infants were assessed for 2-year outcome. There were no significant differences between the two surgical treatment arms, so they were analyzed together. Raw brain volumes increased between baseline and 24 months (median change=361 cc, IQR=293 to 443, p<0.001), but almost all of this increase was seen in the first year (median change=381 cc, IQR=310 to 442, p<0.001), with very little change between 12 and 24 months (median change=-5 cc, IQR=-52 to 42, p=0.66). The fraction of those with a normal brain volume increased from 15% at baseline to 50% at 1 year, but then declined to 18% at 2 years. Substantial normalized brain volume loss was seen in 21% between baseline and year 2 and in 77% between years 1 and 2. The extent of brain growth in the first year was not associated with extent of brain volume changes in the second year. There were significant positive correlations between 2-year brain volume and all BSID-3 scores and BSID-3 changes from baseline.Conclusions and Relevance In sub-Saharan Africa, even after successful surgical treatment of infant post-infectious hydrocephalus, post-treatment brain growth stagnates in the second year. While the reasons for this are unclear, this emphasizes the importance of primary infection prevention strategies along with optimizing the child’s environment to maximize brain growth potential.Trial Registration ClinicalTrials.gov number, NCT01936272Question What is the brain growth and cognitive trajectory of infants treated for post-infectious hydrocephalus in Uganda?Findings In this prospective follow-up of a cohort of 89 infants, early normalization of brain volume after treatment was followed by brain growth stagnation in the second year, with many falling back into the sub-normal range. Poor brain growth was associated with poor cognitive outcome.Meaning Successful surgical treatment of hydrocephalus is not sufficient to allow for adequate brain growth and cognitive development. Interventions aimed at primary infection prevention and reducing comorbidities are needed to improve brain growth potential.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT01936272Funding StatementFunding was provided by National Institutes of Health via the Eunice Kennedy Shriver National Institute of Child Health & Human Development and the Fogarty International Center (project numbers R21TW009612 and R01HD085853), and additional support for image analysis and construction of normative brain growth curves from an NIH Director's Transformative Award (project number R01AI145057).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study received ethics board approval at the CURE Children's Hospital of Uganda, Boston Children's Hospital, The Hospital for Sick Children, and The Pennsylvania State University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData from this study will be made available to qualified researchers by contacting the authors.BSIDBayley Scales of Infant DevelopmentCCHUCURE Children’s Hospital of UgandaCSFcerebrospinal fluidCTcomputed tomographyETV/CPCendoscopic third ventriculostomy plus choroid plexus cauterizationVPSventriculoperitoneal shunt